Abstract：Objective To investigate the clinical effect of Apatinib in the treatment of advanced malignant tumors and its effect on blood pressure.Methods Forty-two patients with advanced malignant tumors admitted to our hospital from January 1, 2016 to December 31, 2017 were enrolled in the study.They were divided into two groups according to random sampling, 21 cases each group.The control group received placebo and nutritional support treatment.The observation group was treated with Apatinib on the basis of the control group, and the total effective rate, adverse reactions,and grade of hypertension were observed and evaluated.Results The total effective rate of the observation group was higher than that of the control group (P＜0.05).The total incidence of adverse reactions in the observation group was higher than that in the control group, the difference was statistically significant (P＜0.05).The total incidence of hypertension in the observation group was higher than that in the control group, and the difference was statistically significant (P＜0.05).There was no significant difference in the grade of hypertension between the two groups (P＞0.05).Conclusion Apatinib has high clinical value in patients with advanced malignant tumors, which is beneficial to prolonging survival.However, the clinical incidence of hypertension is high, and the mechanism of blood pressure elevation needs further discussion.
京公网安备 11010502046607号